South Africa takes the lead in HIV prevention with a groundbreaking twice-a-year injection being added to the Essential Medicines List.

The 2022 plea by an HIV network NGO highlights gaps in procurement and quality of ARV therapy drugs; 16 states yet to file ...

Eswatini on Tuesday became the first African country to receive lenacapavir, the first twice-yearly HIV prevention injection hailed by global health officials as a game-changer in the fight against a ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting injectable drug in the fight against HIV/AIDS.

The Supreme Court on Tuesday said it would hear on December 3 a plea that has raised concerns over the supply and quality of anti-retroviral (ARV) therapy drugs for treating HIV patients in the ...

Largest anti-retroviral (ARV) drugs shipment strengthens partnership and supports Fiji’s 2030 AIDS elimination goal.

Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...

Three people have died at just one community centre on the outskirts of Senegal’s capital, Dakar, following US aid cuts to HIV care. Rachel Schraer meets the women fighting to stop more deaths ...

Administration officials say South Africa has “significant means” to fund a promising new drug, lenacapavir, on its own.

Over 15 children have been diagnosed with HIV in Karachi’s SITE Town, linked to Valika Hospital, prompting urgent local and ...

Nov. 7, 1991, Magic Johnson announced his sudden retirement from the Los Angeles Lakers after testing positive for HIV, the ...